Literature DB >> 28013317

Determination of serum neutrophil gelatinase-associated lipocalin at the early stage of acute pancreatitis.

Mateusz Sporek1, Paulina Dumnicka, Agnieszka Gala-Błądzińska, Małgorzata Mazur-Laskowska, Jerzy Walocha, Piotr Ceranowicz, Zygmunt Warzecha, Artur Dembiński, Marek Kuźniewski, Rafał Olszanecki, Beata Kuśnierz-Cabala2.   

Abstract

AIM: e aim of the study was to assess the diagnostic value of serum concentrations of neutrophil gelatinase-associated lipocalin (sNGAL) for the determination of the severity of acute pancreatitis (AP) at the early stage of the disease. MATERIALS AND
METHOD: The study group consisted of 65 patients(34 men and 31 women),aged 62.2 ± 16.0, admitted to the Surgery Department of the District Hospital in Sucha Beskidzka, Poland, with the diagnosis of AP according to the revised Atlanta classification (2012). sNGAL was measured with ELISA at 24, 48 and 72 hours following the onset of AP symptoms. The correlations were analyzed between sNGAL and clinical, as well as laboratory parameters, used for the assessment of AP severity.
RESULTS: Severe AP was associated with higher sNGAL at 24, 48 and 72 hours, while moderately severe AP was associated with higher sNGAL at 48 and 72 hours as compared to mild disease. The BISAP score ≥3 during the first 24 hours of hospital stay, and the duration of hospital stay were significantly correlated with sNGAL. Also, sNGAL positively correlated with white blood cells, C-reactive protein and fibrinogen and negatively with albumin throughout the study. The diagnostic accuracy of sNGAL for the differentiation between mild AP and more severe disease was 75%, 77% and 85% at 24, 48 and 72 hours, respectively.
CONCLUSIONS: Serum NGAL concentrations are associated with inflammatory markers, BISAP score and the severity of AP. sNGAL may serve as an additional prognostic biomarker in the early assessment of AP severity.

Entities:  

Keywords:  acute pancreatitis; neutrophil gelatinase-associated lipocalin; prognostic markers

Mesh:

Substances:

Year:  2016        PMID: 28013317

Source DB:  PubMed          Journal:  Folia Med Cracov        ISSN: 0015-5616


  5 in total

Review 1.  Lipocalin-2 expression and function in pancreatic diseases.

Authors:  Kristyn Gumpper; Andrew William Dangel; Valentina Pita-Grisanti; Somashekar G Krishna; Luis F Lara; Thomas Mace; Georgios I Papachristou; Darwin L Conwell; Phil A Hart; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2020-01-07       Impact factor: 3.996

2.  Plasma Sphingolipids in Acute Pancreatitis.

Authors:  Tomasz Konończuk; Bartłomiej Łukaszuk; Małgorzata Żendzian-Piotrowska; Andrzej Dąbrowski; Michalina Krzyżak; Lucyna Ostrowska; Krzysztof Kurek
Journal:  Int J Mol Sci       Date:  2017-12-04       Impact factor: 5.923

3.  Serum Uromodulin Levels in Prediction of Acute Kidney Injury in the Early Phase of Acute Pancreatitis.

Authors:  Beata Kuśnierz-Cabala; Agnieszka Gala-Błądzińska; Małgorzata Mazur-Laskowska; Paulina Dumnicka; Mateusz Sporek; Aleksandra Matuszyk; Krzysztof Gil; Piotr Ceranowicz; Jerzy Walocha; Jakub Kucharz; Michał Pędziwiatr; Krzysztof Bartuś; Rafał Trąbka; Marek Kuźniewski
Journal:  Molecules       Date:  2017-06-14       Impact factor: 4.411

4.  Predictors of acute pancreatitis with low elevation of serum amylase.

Authors:  Wandong Hong; Wujun Geng; Bicheng Chen; Zarrin Basharat; Qingsong Wu; Vincent Zimmer; Mengtao Zhou
Journal:  Ther Clin Risk Manag       Date:  2017-12-14       Impact factor: 2.423

5.  The Acute Phase Response Is a Prominent Renal Proteome Change in Sepsis in Mice.

Authors:  Beáta Róka; Pál Tod; Tamás Kaucsár; Matej Vizovišek; Robert Vidmar; Boris Turk; Marko Fonović; Gábor Szénási; Péter Hamar
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.